BOLALARDA GASTRODUODENIT: MUAMMOGA ZAMONAVIY QARASHLAR
##plugins.themes.newtheme.article.abstract##
Adabiyotlar sharhi bolalarda gastroduodenit muammosining hozirgi holatiga bag‘ishlangan. Kasallikning tarqalishi va yoshga xos klinik ko‘rinishi bo‘yicha joriy ma'lumotlar keltirilgan. Etakchi etiologik omillar ko‘rib chiqiladi, ular orasida Helicobacter pylori asosiy rol o‘ynaydi, shuningdek, noto‘g‘ri ovqatlanish, stress ta'siri va genetik moyillik. Tasniflashlar evolyutsiyasi morfologik, etiologik va klinik-funksional xususiyatlarni hisobga olgan holda tavsiflanadi va SDDS kontseptsiyasining ilmiy maqsadlar uchun ahamiyati ta'kidlanadi. Zamonaviy diagnostika algoritmlari, jumladan, bir nechta maqsadli biopsiya bilan endoskopiya, invaziv bo‘lmagan ^13C-ureaza va najas antigeni testlari, "gastropanel" va yallig‘lanishning istiqbolli belgilari tasvirlangan. Hozirgi eradikatsiya va antisekretor terapiya sxemalari (proton pompasi ingibitorlari, kaliy blokerlari, vismut o‘z ichiga olgan to‘rtlik va ketma-ket rejimlar), gastroprotektorlarning roli, probiotiklar va parhez terapiyasi ko‘rib chiqiladi. Profilaktika va reabilitatsiya tamoyillari, shu jumladan turmush tarzi va psixo-emotsional holatni tuzatish. Quyidagi hal qilinmagan muammolar ta'kidlangan: H. pylori antibiotiklarga chidamliligining o‘sishi, lPP larni uzoq muddatli qo‘llash xavfsizligi, tasdiqlangan invaziv bo‘lmagan biomarkerlarning yo‘qligi va bolalar kasalliklari faolligi shkalasi. Ko‘p markazli tadqiqotlar va endoskopik baholashni ob'ektivlashtirish uchun II algoritmlarini ishlab chiqish zarurati qayd etilgan.
##plugins.themes.newtheme.authorinfo##
##plugins.themes.newtheme.citations##
Xu Y, Chen F, Wen H. Global incidence and prevalence of gastritis and duodenitis from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. J Gastroenterol Hepatol. 2024;39(8):1563-1570.
Park S, Liu M, Huang S. Association of polygenic variants involved in immunity and inflammation with duodenal ulcer risk and their interaction with irregular eating habits. Nutrients 2023; 15: 296.
Mayo Clinic on Digestive Health, Fourth Edition. Mayo Clinic Press [Internet]. [cited 2023 Sep 30]. Available from: https://mcpress.mayoclinic.org/product/mayo‐clinic‐on‐digestive‐health/.
Duodenitis: causes, symptoms, and treatment [Internet]. [cited 2023 Sep 30]. Available from: https://www.webmd.com/digestive‐disorders/what‐is‐duodenitis
Nair MRB, Chouhan D, Sen Gupta S, Chattopadhyay S. Fermented foods: are they tasty medicines for Helicobacter pylori associated peptic ulcer and gastric cancer? Front. Microbiol. 2016; 7: 1148.
Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects. World J. Gastroenterol. 2018; 24: 3071–3089.
Homan M, Jones NL, Bontems P, et al. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). J Pediatr Gastroenterol Nutr. 2024;79(3):758-785.
Josyabhatla R, Wood ML, Gafur A, et al. Rising prevalence of mild chronic gastritis in children: a single-center experience. Pediatr Dev Pathol. 2024;27(3):235-240.
Chakhachiro Z, Saroufim M, Safadi B, et al. Plasma cells and lymphoid aggregates in sleeve gastrectomy specimens: normal or gastritis? Medicine (Baltimore). 2020;99(6):e18926.
Rosas-Blum E, Tatevian N, Hashmi SS, Rhoads JM, Navarro F. Non-specific gastric inflammation in children is associated with proton pump inhibitor treatment for more than 6 weeks. Front Pediatr. 2014;2:3.
Miller GC, Reid AS, Brown IS. The pathological findings seen in laparoscopic sleeve gastrectomies for weight loss. Pathology. 2016;48(3):228-232.
Thakkar K, Chen L, Tessier ME, Gilger MA. Outcomes of children after esophagogastroduodenoscopy for chronic abdominal pain. Clin Gastroenterol Hepatol. 2014;12(6):963-969.
Walsh CM, Lightdale JR; PEnQuIN Working Group. Quality standards and indicators for pediatric endoscopy: an ASGE-endorsed guideline. Gastrointest Endosc. 2022;96(4):593-602.
Ding YM, Duan M, Han ZX, et al. Bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized clinical trial of 10 and 14 days. Dig Dis Sci. 2024;69(7):2540-2547.
Alla K, Agrawal R, Vikram NK, et al. Safety of proton pump inhibitors in pediatric population: a systematic review. Clin Exp Pediatr. 2024;67(2):123-132.
Sturm AL, Lundholm C, Fang F, et al. Proton pump inhibitor use and risk of serious infections in young children. JAMA Pediatr. 2023;177(4):351-359.
Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021.
Swital M, Drouin J, Miranda S, Bakchine S, Botton J, Dray-Spira R.Mult Scler. 2024 Feb;30(2):227-237. doi: 10.1177/13524585231223395. Epub 2024 Jan 27.PMID: 38281078
Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany.
Mauritz MD, von Both U, Dohna-Schwake C, Gille C, Hasan C, Huebner J, Hufnagel M, Knuf M, Liese JG, Renk H, Rudolph H, Schulze-Sturm U, Simon A, Stehling F, Tenenbaum T, Zernikow B.Eur J Pediatr. 2024 Mar;183(3):987-999. doi: 10.1007/s00431-023-05401-6. Epub 2024 Jan 3.PMID: 38172444 Proton-Pump Inhibitors and Fat Absorption in Cystic Fibrosis and Pancreatic Insufficiency: A Randomized Crossover Pilot Trial.
Phillips AE, Brownell JN, Tindall A, Kiernan BD, Patel D, Gelfond D, Stallings VA.Dig Dis Sci. 2025 Mar;70(3):968-977. doi: 10.1007/s10620-024-08728-8. Epub 2024 Nov 13.PMID: 39537890 .
Brief Resolved Unexplained Events Symptoms Frequently Result in Inappropriate Gastrointestinal Diagnoses and Treatment.
Duncan DR, Golden C, Growdon AS, Larson K, Rosen RL.J Pediatr. 2024 Sep;272:114128. doi: 10.1016/j.jpeds.2024.114128. Epub 2024 May 28.PMID: 38815745
Canani RB, Cirillo P, Di Costanzo M, et al. Saccharomyces boulardii in the prevention and treatment of antibiotic-associated diarrhea in children: a meta-analysis of randomized trials. Nutrients. 2024;16(2):355.